Program
PALI-2108
A development code.
Its studies are mostly in Colitis, Ulcerative · Crohn Disease, led by Palisade Bio.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Palisade Bio | 32 open or running | phase 2since Sep 21, 2026 | Oct 25, 2024 | Oct 2027phase 2 · NCT07845487 |
Also a collaborator on its studies: altasciences-company-inc.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 25, 2024First study: phase 1 study in Colitis, UlcerativeFirst studyNCT06663605 · 89 enrolled · Canada
- Nov 24, 2025Phase 1 study in Inflammatory Bowel DiseasesNCT07428096 · 6 enrolled · Canada
- Sep 21, 2026Phase 2 study in Colitis, UlcerativePhase 2 reachedNCT07845487 · 204 planned · United States, Canada, Czechia and more
Ahead
- Oct 2027Primary completion: phase 2 study in Colitis, UlcerativeNCT07845487
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07845487Colitis, Ulcerative · United States, Canada, Czechia and more | 2 | Recruiting | Oct 2027 | 204 |
| NCT07428096Inflammatory Bowel Diseases · Canada | 1 | Active, not recruiting | Jan 30, 2026 | 6 |
| NCT06663605Colitis, Ulcerative · Canada | 1 | Completed | Jul 7, 2025 | 89 |
How it is read
Names in the registry
- “PALI-2108”, 4 entries
Codes read as this program: PALI2108.
Conditions, from the studies’ own filings
- Colitis, Ulcerative, 2 studies
- Crohn Disease, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.